LAURA BROWN: Open Payments
NPI 1790233864 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 30 payments from 8 companies in 2025. Trend: 2023 $154 · 2024 $252 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $258 |
| Endologix LLC | 1 | $110 |
| SCPHARMACEUTICALS INC. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Abbott Laboratories | 1 | $62 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $48 |
Products named: Kerendia, Torus Stent Graft System, FUROSCIX, FARXIGA, LEQVIO, CARDIOMEMS, OPSUMIT.
Industry payments across TX — which companies pay providers there.
